About The Medical Condition Evaluation Studies, FDA Phase III
Find the definition of the medical term Evaluation Studies, FDA Phase III. Evaluation Studies, FDA Phase III defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Evaluation Studies, FDA Phase III
| Evaluation Studies, FDA Phase III Medical Condition |
|---|
What's The Definition Of The Medical Condition Evaluation Studies, FDA Phase III?
Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Intelligence Tests ‐ Standardized tests that measure the present general ability or…
- Choking ‐ Any hindrance to the passage of air into and out of…
- Tracts, Olfactory ‐ Set of nerve fibers conducting impulses from olfactory receptors…
- Thrombolysin ‐ A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN…
- Mercury Poisoning, Nervous System ‐ Neurologic disorders associated with exposure to inorganic and…
- Bauxite ‐ An oxide of aluminum, occurring in nature as various minerals…
- Initiation, Peptide Chain ‐ The process whereby the formation of a peptide chain is started.…
- Macrosomias, Fetal ‐ A complication of several conditions including DIABETES MELLITUS…
- Adenocarcinoma, Sebaceous ‐ A malignant tumor composed of cells showing differentiation toward…
- Switching, Isotype ‐ Gene rearrangement of the B-lymphocyte which results in a substitution…